» Articles » PMID: 36588100

Diffuse Alveolar Hemorrhage in Children with Interstitial Lung Disease: Determine Etiologies!

Abstract

Objective: Diffuse alveolar hemorrhage (DAH) in children is a rare condition resulting from different underlying diseases. This study aimed at describing characteristics and diagnostic measures in children with ILD (children's interstitial lung disease, chILD) and DAH to improve the diagnostic approach by increasing clinician's awareness of diagnostic shortcomings.

Patients And Methods: A retrospective data analysis of patients with ILD and DAH treated in our own or collaborating centers between 01/07/1997 and 31/12/2020 was performed. Data on clinical courses and diagnostic measures were systematically retrieved as case-vignettes and investigated. To assess suitability of diagnostic software-algorithms, the Human Phenotype Ontology (HPO) was revised and expanded to optimize conditions of its associated tool the "Phenomizer."

Results: For 97 (74%) of 131 patients, etiology of pulmonary hemorrhage was clarified. For 34 patients (26%), no underlying condition was found (termed as idiopathic pulmonary hemorrhage, IPH). Based on laboratory findings or clinical phenotype/comorbidities, 20 of these patients were assigned to descriptive clusters: IPH associated with autoimmune features (9), eosinophilia (5), renal disease (3) or multiorgan involvement (3). For 14 patients, no further differentiation was possible.

Conclusion: Complete and sometimes repeated diagnostics are essential for establishing the correct diagnosis in children with DAH. We suggest assignment of patients with IPH to descriptive clusters, which may also guide further research. Digital tools such as the Phenomizer/HPO are promising, but need to be extended to increase diagnostic accuracy.

Citing Articles

Pediatric cardiac patients with pulmonary hemorrhage supported on ECMO: An ELSO registry study.

Anton-Martin P, Young C, Sandhu H, Vellore S J Extra Corpor Technol. 2025; 57(1):2-8.

PMID: 40053851 PMC: 11888591. DOI: 10.1051/ject/2024038.


The Clinical Approach to Interstitial Lung Disease in Childhood: A Narrative Review Article.

Drobnakova S, Vargova V, Barkai L Children (Basel). 2024; 11(8).

PMID: 39201839 PMC: 11352674. DOI: 10.3390/children11080904.


The Human Phenotype Ontology in 2024: phenotypes around the world.

Gargano M, Matentzoglu N, Coleman B, Addo-Lartey E, Anagnostopoulos A, Anderton J Nucleic Acids Res. 2023; 52(D1):D1333-D1346.

PMID: 37953324 PMC: 10767975. DOI: 10.1093/nar/gkad1005.


Diffuse alveolar haemorrhage in children: an international multicentre study.

Ring A, Schwerk N, Kiper N, Tana Aslan A, Aurora P, Ayats R ERJ Open Res. 2023; 9(2).

PMID: 37101741 PMC: 10123512. DOI: 10.1183/23120541.00733-2022.

References
1.
Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M . Adult-onset eosinophilic airway diseases. Allergy. 2020; 75(12):3087-3099. DOI: 10.1111/all.14620. View

2.
Boussouar S, Benattia A, Escudie J, Gibault L, Capron F, Legrand A . Vascular Ehlers-Danlos syndrome (vEDS): CT and histologic findings of pleural and lung parenchymal damage. Eur Radiol. 2021; 31(8):6275-6285. DOI: 10.1007/s00330-021-07710-6. View

3.
Baas M, Stubbs A, van Zessen D, Galjaard R, van der Spek P, Hovius S . Identification of Associated Genes and Diseases in Patients With Congenital Upper-Limb Anomalies: A Novel Application of the OMT Classification. J Hand Surg Am. 2017; 42(7):533-545.e4. DOI: 10.1016/j.jhsa.2017.03.043. View

4.
Alimi A, Taytard J, Taam R, Houdouin V, Forgeron A, Lubrano Lavadera M . Pulmonary hemosiderosis in children with Down syndrome: a national experience. Orphanet J Rare Dis. 2018; 13(1):60. PMC: 5910623. DOI: 10.1186/s13023-018-0806-6. View

5.
Papiris S, Manali E, Kalomenidis I, Kapotsis G, Karakatsani A, Roussos C . Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care. 2007; 11(3):213. PMC: 2206392. DOI: 10.1186/cc5778. View